Shares of Lemonade surged 10.2% to $53.22 on August 7, clawing back a chunk of last week's brutal post-earnings selloff that erased nearly a quarter of the stock's value in a single session. The bounce forces investors to confront whether the July 29 plunge was an overreaction — or an overdue reckoning for a company still losing money.
The Selloff Was About a Tiny Guidance Miss, Not a Broken Business. The high end of Lemonade's full-year in-force premium guidance ($1.632–$1.639 billion) fell short of Wall Street's target of more than $1.642 billion — a gap of roughly $3 million. The guidance "wasn't bad at all — it simply wasn't as aggressive as Wall Street's target." Yet the stock cratered from $62.11 to $47.38, a move that priced in far worse than a rounding error on growth forecasts. Morgan Stanley had downgraded LMND earlier in July, arguing additional catalysts were needed to justify the valuation , leaving the stock vulnerable.
Revenue Is Booming, but the Bottom Line Still Bleeds. Revenue jumped 79% to $294 million and gross profit rose 76% to a record $113 million. Yet net loss was $43.4 million ($0.56/share) , barely improved from a year ago. The company maintained its full-year adjusted EBITDA loss guidance of $47–$51 million and guided to a sequentially wider Q3 loss — not the trajectory bulls hoped for heading into the profitability milestone. Management still points to implied Q4 adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of about $8 million , which would be the company's first-ever profitable quarter by that measure.
A CFO Changing of the Guard Adds Uncertainty at the Worst Time. Longtime CFO Tim Bixby, in the role since 2017, will move to Lemonade's board effective January 1, 2027, with SVP Finance Nick Stead succeeding him.
Bixby sold 73,000 shares on July 7 at ~$79 per share under a prearranged plan — well above today's price. Leadership transitions during a critical march toward profitability can rattle investors even when the handoff is orderly.
The Bounce May Have Legs — If Q4 Delivers. A new financing deal with reinsurer Hannover Re provides up to $250 million to fund future sales and marketing , giving Lemonade growth capital without diluting shareholders. At $53, the stock trades at roughly 3× forward sales — cheap for 65% revenue growth, expensive for a company that has never turned an annual profit. The entire thesis now rests on whether that Q4 milestone holds.